These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3508348)

  • 21. [Multiple sclerosis and the histocompatibility system].
    Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):167-71. PubMed ID: 6176089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epidemiological and clinical studies of multiple sclerosis in the provinces of Naples and Avellino].
    Palma V; Ciambellini M; Buscaino GA
    Acta Neurol (Napoli); 1981 Feb; 3(1):280-90. PubMed ID: 7246305
    [No Abstract]   [Full Text] [Related]  

  • 23. Multiple sclerosis in 3 gipsy and 2 partly gipsy subjects (a clinical and immunogenetic study).
    Pálffy G; Gyódi E; Petrányi G
    Acta Med Hung; 1986; 43(1):31-7. PubMed ID: 3774417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [HLA antigens in multiple sclerosis].
    Vymazal J; Krásenská J; Korinková P; Májský A
    Cesk Neurol Neurochir; 1980 Sep; 43(5):284-9. PubMed ID: 7418054
    [No Abstract]   [Full Text] [Related]  

  • 25. Postpartum-activation of multiple sclerosis is associated with down-regulation of tolerogenic HLA-G.
    Airas L; Nikula T; Huang YH; Lahesmaa R; Wiendl H
    J Neuroimmunol; 2007 Jul; 187(1-2):205-11. PubMed ID: 17561269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The HLA locus and multiple sclerosis in Sicily.
    Brassat D; Salemi G; Barcellos LF; McNeill G; Proia P; Hauser SL; Oksenberg JR; Savettieri G
    Neurology; 2005 Jan; 64(2):361-3. PubMed ID: 15668443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis.
    Brautbar C; Amar A; Cohen I; Kahana E; Cohen T; Bloch D; Grosse-Wilde H; Alter M
    Isr J Med Sci; 1982 May; 18(5):631-4. PubMed ID: 7096048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicenter study of the incidence of multiple sclerosis in Italy: design of the study.
    Comi G
    Ital J Neurol Sci; 1987 Jun; Suppl 6():21-5. PubMed ID: 3654177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multiple sclerosis in Umbria. (Epidemiological study)].
    Paci A; Borri P
    Riv Neurobiol; 1969; 15(4):797-805. PubMed ID: 5403692
    [No Abstract]   [Full Text] [Related]  

  • 30. Allergy and multiple sclerosis: a population-based case-control study.
    Pedotti R; Farinotti M; Falcone C; Borgonovo L; Confalonieri P; Campanella A; Mantegazza R; Pastorello E; Filippini G
    Mult Scler; 2009 Aug; 15(8):899-906. PubMed ID: 19667018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor 2 allele does not contribute to increased tumor necrosis factor-alpha production in Sardinian multiple sclerosis.
    Sotgiu S; Pugliatti M; Serra C; Rosati G; Dolei A; Marrosu MG
    Ann Neurol; 1999 Nov; 46(5):799-800. PubMed ID: 10554002
    [No Abstract]   [Full Text] [Related]  

  • 32. Mortality study on multiple sclerosis in the province of Ferrara, northern Italy, 1968 through 1989.
    Govoni V; Casetta I; Granieri E; Vernonesi V; Malagù S; Tola MR; Paolino E; Fainardi E; Monetti VC; Aiello I
    Acta Neurol (Napoli); 1993 Jun; 15(3):161-76. PubMed ID: 8237514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Disseminated sclerosis. Possible correlation between clinical forms and HLA groups (author's transl)].
    Madigand M; Fauchet R; Oger J; Sabouraud O
    Nouv Presse Med; 1981 Jun; 10(28):2349-52. PubMed ID: 7267340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Histocompatibility patterns in multiple sclerosis. Findings of an epidemiological study (author's transl)].
    Poser S; Ritter G; Bauer HJ; Kuwert EK; Höher PG; Grosse-Wilde H; Hierholzer E
    Nervenarzt; 1981 Jun; 52(6):326-8. PubMed ID: 6973699
    [No Abstract]   [Full Text] [Related]  

  • 35. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
    Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
    Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis.
    Silva AM; Bettencourt A; Pereira C; Santos E; Carvalho C; Mendonça D; Costa PP; Monteiro L; Martins B
    Mult Scler; 2009 Jun; 15(6):771-4. PubMed ID: 19482867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [HLA antigen study in familial cases of disseminated sclerosis and in twins].
    Zavalishin IA; Tananov AT; Nevskaia OM; Kulov BB
    Vrach Delo; 1984 Aug; (8):91-3. PubMed ID: 6542279
    [No Abstract]   [Full Text] [Related]  

  • 38. Bayesian mapping of multiple sclerosis prevalence in the province of Pavia, northern Italy.
    Bergamaschi R; Montomoli C; Candeloro E; Monti MC; Cioccale R; Bernardinelli L; Fratino P; Cosi V;
    J Neurol Sci; 2006 May; 244(1-2):127-31. PubMed ID: 16527310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The histocompatibility (HLA) antigen distribution in multiple sclerosis patients in Zimbabwe.
    Lowe RF; Moore HH; Briggs BR
    Cent Afr J Med; 1980 Nov; 26(11):234-6. PubMed ID: 7471189
    [No Abstract]   [Full Text] [Related]  

  • 40. HLA-patterns in patients with multiple sclerosis and type I diabetes mellitus: evidence for possible mutual exclusion of both diseases.
    Lobnig BM; Chantelau E; Vidgrén G; Van Landeghem AA; Kinnunen L; Tuomilehto-Wolf E
    Diabetes Metab; 2002 Jun; 28(3):217-21. PubMed ID: 12149602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.